Data from a recently completed Phase 2 Trial with 68 participants( 14 Alzheimers and 54 Parkinsons) . They have said that data should be available this quarter and with the Biogen Clock of 90 Days ticking ,
I imagine all kitchen sinks will be thrown into the market by ANVS, SAVA and AVXL during this time frame. If they miss this window to stop Biogen it will be a true human tragedy (IMO)
Recent ANVS News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 11:15:54 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 12:09:07 PM
- IBN Announces Latest Episode of The Bell2Bell Podcast Featuring Annovis Bio CEO Dr. Maria Maccecchini, Live from AAIC 2024 • GlobeNewswire Inc. • 08/05/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 12:05:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 08:05:43 PM
- Paramount-Skydance $28B Merger, Boeing Agrees to Plead Guilty with $243.6M Fine, and More News • IH Market News • 07/08/2024 10:37:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 10:05:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 09:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:32:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:05:24 PM
- Annovis Announces New Publication in a Peer-Reviewed Journal • GlobeNewswire Inc. • 05/21/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:05:46 PM
- Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/13/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:11:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:03:33 PM
- Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 09:12:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:11:19 PM
- Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders • GlobeNewswire Inc. • 05/06/2024 11:30:00 AM
- Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease • GlobeNewswire Inc. • 04/29/2024 02:10:00 PM
- Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/02/2024 11:30:00 AM
- US Stock Movers Before Market: Beyond Meat, eBay, First Solar, Urban Outfitters… • IH Market News • 02/28/2024 12:08:14 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/12/2024 07:00:23 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/01/2024 09:05:20 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM